Priming with CpG-enriched plasmid and boosting with protein formulated with CpG oligodeoxynucleotides and Quil A induces strong cellular and humoral immune responses to hepatitis C virus NS3

Journal of General Virology

Volumn 85, Issue 6, 2004, Pages 1533-1543

  Yu, Hong ^a   Babiuk, Lorne A ^a   van Drunen Littel van den Hurk, Sylvia ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HEPATITIS C VACCINE; IMMUNOLOGICAL ADJUVANT; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NONSTRUCTURAL PROTEIN 3; OLIGODEOXYNUCLEOTIDE; QUIL A; UNCLASSIFIED DRUG; VIRUS PROTEIN; CPG OLIGONUCLEOTIDE; CPG-OLIGONUCLEOTIDE; HEPATITIS C ANTIBODY; HEPATITIS VACCINE; IMMUNOGLOBULIN G; NS3 PROTEIN, HEPATITIS C VIRUS; OLIGODEOXYRIBONUCLEOTIDE; RECOMBINANT VACCINE; SAPONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL KILLING; CELLULAR IMMUNITY; CONTROLLED STUDY; CPG ISLAND; CYTOTOXIC T LYMPHOCYTE; DRUG CYTOTOXICITY; DRUG FORMULATION; HEPATITIS C VIRUS; HUMORAL IMMUNITY; IMMUNOSTIMULATION; INBREEDING; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN MOTIF; SWINE; TH1 CELL; TH2 CELL; VACCINATION; ANIMAL; BAGG ALBINO MOUSE; BLOOD; FEMALE; GENETICS; IMMUNIZATION; IMMUNOLOGY;

ANIMALIA; HEPATITIS C VIRUS;

ANIMALS; CPG ISLANDS; FEMALE; HEPACIVIRUS; HEPATITIS C ANTIBODIES; IMMUNIZATION; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; OLIGODEOXYRIBONUCLEOTIDES; PLASMIDS; SAPONINS; SWINE; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, SYNTHETIC; VIRAL HEPATITIS VACCINES; VIRAL NONSTRUCTURAL PROTEINS;

EID: 2942685438     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.79821-0     Document Type: Article

References (59)

1. Acosta-Rivero, N., Alvarez-Obregon, J. C., Musacchio, A., Falcon, V., Duenas-Carrera, S., Marante, J., Menendez, I. & Morales, J. (2002). In vitro self-assembled HCV core virus-like particles induce a strong antibody immune response in sheep. Biochem Biophys Res Commun 290, 300-304.
2. Anwer, K., Earle, K. A., Shi, M. & 11 other authors (1999). Synergistic effect of formulated plasmid and needle-free injection for genetic vaccines. Pharm Res 16, 889-895.
3. Baca-Estrada, M. E., Snider, M., Tikoo, S. K., Harland, R., Babiuk, L. A. & van Drunen Littel-van den Hurk, S. (1996). Immunogenicity of bovine herpesvirus 1 glycoprotein D in mice: effect of antigen form on the induction of cellular and humoral immune responses. Viral Immunol 9, 11-22.
4. Barr, I. G. & Mitchell, G. F. (1996). ISCOMs (immunostimulating complexes): the first decade. Immunol Cell Biol 74, 8-25.
5. Battegay, M., Fikes, J., Di Bisceglie, A. M. & 11 other authors (1995). Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2·1 molecules. J Virol 69, 2462-2470.
6. Boyer, J. D., Wang, B., Ugen, K. E. & 9 other authors (1996). In vivo protective anti-HIV immune responses in non-human primates through DNA immunization. J Med Primatol 25, 242-250.
7. Brinster, C., Chen, M., Boucreux, D., Paranhos-Baccala, G., Liljestrom, P., Lemmonier, F. & Inchauspe, G. (2002). Hepatitis C virus non-structural protein 3-specific cellular immune responses following single or combined immunization with DNA or recombinant Semliki Forest virus particles. J Gen Virol 83, 369-381.
8. Bryan, L. A., Griebel, P. J., Haines, D. M., Davis, W. C. & Allen, J. R. (1988). Immunocytochemical identification of bovine Langerhans cells by use of a monoclonal antibody directed against class II MHC antigens. J Histochem Cytochem 36, 991-995.
9. Bukh, J., Forns, X., Emerson, S. U. & Purcell, R. H. (2001). Studies of hepatitis C virus in chimpanzees and their importance for vaccine development. Intervirology 44, 132-142.
10. Choo, Q. L., Kuo, G., Ralston, R. & 15 other authors (1994). Vaccination of chimpanzees against infection by the hepatitis C virus. Proc Natl Acad Sci U S A 91, 1294-1298.
11. Chu, R. S., Targoni, O. S., Krieg, A. M., Lehmann, P. V. & Harding, C. V. (1997). CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med 186, 1623-1631.
12. Cooper, S., Erickson, A. L., Adams, E. J., Kansopon, J., Weiner, A. J., Chien, D. Y., Houghton, M., Parham, P. & Walker, C. M. (1999). Analysis of a successful immune response against hepatitis C virus. Immunity 10, 439-449.
13. Cox, J. C. & Coulter, A. R. (1997). Adjuvants - a classification and review of their modes of action. Vaccine 15, 248-256.
14. Davis, H. L. (2000). Use of CpG DNA for enhancing specific immune responses. Curr Top Microbiol Immunol 247, 171-183.
15. Davis, H. L., Weeratna, R., Waldschmidt, T. J., Tygrett, L., Schorr, J. & Krieg, A. M. (1998). CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J Immunol 160, 870-876.
16. Davis, H. L., Suparto, I. I., Weeratna, R. R. & 10 other authors (2000). CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans. Vaccine 18, 1920-1924.
17. + T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection. J Virol 71, 6011-6019.
18. Donnelly, J. J., Friedman, A., Martinez, D., Montgomery, D. L., Shiver, J. W., Motzel, S. L., Ulmer, J. B. & Liu, M. A. (1995). Preclinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virus. Nat Med 1, 583-587.
19. Duenas-Carrera, S., Vina, A., Martinez, R. & 7 other authors (2004). Immunization with a DNA vaccine encoding the hepatitis-C-virus structural antigens elicits a specific immune response against the capsid and envelope proteins in rabbits and Mecaca irus (crab-eating macaque monkeys). Biotechnol Appl Biochem 39, 249-255.
20. Encke, J., zu Putlitz, J., Geissler, M. & Wands, J. R. (1998). Genetic immunization generates cellular and humoral immune responses against the nonstructural proteins of the hepatitis C virus in a murine model. J Immunol 161, 4917-4923.
21. Farci, P., Alter, H. J., Wong, D. C., Miller, R. H., Govindarajan, S., Engle, R., Shapiro, M. & Purcell, R. H. (1994). Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci U S A 91, 7792-7796.
22. Fynan, E. F., Webster, R. G., Fuller, D. H., Haynes, J. R., Santoro, J. C. & Robinson, H. L. (1993). DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc Natl Acad Sci U S A 90, 11478-11482.
23. Geissler, M., Gesien, A., Tokushige, K. & Wands, J. R. (1997). Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids. J Immunol 158, 1231-1237.
24. Grakoui, A., Wychowski, C., Lin, C., Feinstone, S. M. & Rice, C. M. (1993). Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol 67, 1385-1395.
25. Hartmann, G., Weeratna, R. D., Ballas, Z. K. & 9 other authors (2000). Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo. J Immunol 164, 1617-1624.
26. Hijikata, M., Kato, N., Ootsuyama, Y., Nakagawa, M. & Shimotohno, K. (1991). Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc Natl Acad Sci U S A 88, 5547-5551.
27. Hoofnagle, J. H. (1997). Hepatitis C: the clinical spectrum of disease. Hepatology 26, 15S-20S.
28. Inchauspe, G. & Feinstone, S. (2003). Development of a hepatitis C virus vaccine. Clin Liver Dis 7, 243-259.
29. Ioannou, X. P., Griebel, P., Hecker, R., Babiuk, L. A. & van Drunen Littel-van den Hurk, S. (2002a). The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligodeoxynucleotides. J Virol 76, 9002-9010.
30. Ioannou, X. P., Gomis, S. M., Karvonen, B., Hecker, R., Babiuk, L. A. & van Drunen Littel-van den Hurk, S. (2002b). CpG-containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpesvirus glycoprotein. Vaccine 21, 127-137.
31. Ioannou, X. P., Griebel, P., Mena, A., Gomis, S. M., Godson, D. L., Mutwiri, G., Hecker, R., Babiuk, L. A. & van Drunen Littel-van den Hurk, S. (2003). Safety of CpG oligodeoxynucleotides in veterinary species. Antisense Nucleic Acid Drug Dev 13, 157-167.
32. Jiao, X., Wang, R. Y., Feng, Z., Alter, H. J. & Shih, J. W. (2003). Modulation of cellular immune response against hepatitis C virus nonstructural protein 3 by cationic liposome encapsulated DNA immunization. Hepatology 37, 452-460.
33. Jin, L. & Peterson, D. L. (1995). Expression, isolation, and characterization of the hepatitis C virus ATPase/RNA helicase. Arch Biochem Biophys 323, 47-53.
34. Kim, J. J., Yang, J. S., Manson, K. H. & Weiner, D. B. (2001). Modulation of antigen-specific cellular immune responses to DNA vaccination in rhesus macaques through the use of IL-2, IFN-gamma, or IL-4 gene adjuvants. Vaccine 19, 2496-2505.
35. Klinman, D. M. (2003). CpG DNA as a vaccine adjuvant. Expert Rev Vaccines 2, 305-315.
36. Klinman, D. M., Ishii, K. J. & Verthelyi, D. (2000). CpG DNA augments the immunogenicity of plasmid DNA vaccines. Curr Top Microbiol Immunol 247, 131-142.
37. Krieg, A. M., Yi, A. K., Schorr, J. & Davis, H. L. (1998). The role of CpG dinucleotides in DNA vaccines. Trends Microbiol 6, 23-27.
38. Kurokohchi, K., Akatsuka, T., Pendleton, C. D., Takamizawa, A., Nishioka, M., Battegay, M., Feinstone, S. M. & Berzofsky, J. A. (1996). Use of recombinant protein to identify a motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 region. J Virol 70, 232-240.
39. + T helper (Th) cell responses to the hepatitis C virus non-structural 3 (NS3) protein: NS3 primes Th1-like responses more effectively as a DNA-based immunogen than as a recombinant protein. J Gen Virol 82, 1299-1308.
40. Lewis, P. J., van Drunen Littel-van den Hurk, S. & Babiuk, L. A. (1999). Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response. J Virol 73, 10214-10223.
41. Manickan, E., Karem, K. L. & Rouse, B. T. (1997). DNA vaccines - a modern gimmick or a boon to vaccinology? Crit Rev Immunol 17, 139-154.
42. Pancholi, P., Perkus, M., Tricoche, N., Liu, Q. & Prince, A. M. (2003). DNA immunization with hepatitis C virus (HCV) polycistronic genes or immunization by HCV DNA priming-recombinant canarypox virus boosting induces immune responses and protection from recombinant HCV-vaccinia virus infection in HLA-A2.1-transgenic mice. J Virol 77, 382-390.
43. Pontarollo, R. A., Babiuk, L. A., Hecker, R. & Van Drunen Littel-Van Den Hurk, S. (2002). Augmentation of cellular immune responses to bovine herpesvirus-1 glycoprotein D by vaccination with CpG-enhanced plasmid vectors. J Gen Virol 83, 2973-2981.
44. Poynard, T., Marcellin, P., Lee, S. S. & 8 other authors (1998). Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT). Lancet 352, 1426-1432.
45. Rankin, R., Pontarollo, R., Ioannou, X., Krieg, A. M., Hecker, R., Babiuk, L. A. & van Drunen Littel-van den Hurk, S. (2001 . CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved. Antisense Nucleic Acid Drug Dev 11, 333-340.
46. Rankin, R., Pontarollo, R., Gomis, S. & 7 other authors (2002). CpG-containing oligodeoxynucleotides augment and switch the immune responses of cattle to bovine herpesvirus-1 glycoprotein D. Vaccine 20, 3014-3022.
47. Raz, E., Tighe, H., Sato, Y., Corr, M., Dudler, J. A., Roman, M., Swain, S. L., Spiegelberg, H. L. & Carson, D. A. (1996). Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc Natl Acad Sci U S A 93, 5141-5145.
48. Rimmelzwaan, G. F. & Osterhaus, A. D. (1995). A novel generation of viral vaccines based on the ISCOM matrix. Pharm Biotechnol 6, 543-558.
49. Saito, I., Miyamura, T., Ohbayashi, A. & 10 other authors (1990). Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci U S A 87, 6547-6549.
50. Samani, T. D., Jolles, B. & Laigle, A. (2001). Best minimally modified antisense oligonucleotides according to cell nuclease activity. Antisense Nucleic Acid Drug Dev 11, 129-136.
51. Shimizu, Y. K., Feinstone, S. M., Kohara, M., Purcell, R. H. & Yoshikura, H. (1996). Hepatitis C virus: detection of intracellular virus particles by electron microscopy. Hepatology 23, 205-209.
52. Song, M. K., Lee, S. W., Suh, Y. S., Lee, K. J. & Sung, Y. C. (2000). Enhancement of immunoglobulin G2a and cytotoxic T-lymphocyte responses by a booster immunization with recombinant hepatitis C virus E2 protein in E2 DNA-primed mice. J Virol 74, 2920-2925.
53. Stittelaar, K. J., Boes, J., Kersten, G. F. & 8 other authors (2000). In vivo antibody response and in vitro CTL activation induced by selected measles vaccine candidates, prepared with purified Quil A components. Vaccine 18, 2482-2493.
54. Takaki, A., Wiese, M., Maertens, G., Depla, E., Seifert, U., Liebetrau, A., Miller, J. L., Manns, M. P. & Rehermann, B. (2000). Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med 6, 578-582.
55. Tedeschi, V., Akatsuka, T., Shih, J. W., Battegay, M. & Feinstone, S. M. (1997). A specific antibody response to HCV E2 elicited in mice by intramuscular inoculation of plasmid DNA containing coding sequences for E2. Hepatology 25, 459-462.
56. Thimme, R., Oldach, D., Chang, K. M., Steiger, C., Ray, S. C. & Chisari, F. V. (2001). Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 194, 1395-1406.
57. Ulmer, J. B., Donnelly, J. J., Parker, S. E. & 7 other authors (1993). Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259, 1745-1749.
58. Wedemeyer, H., Gagneten, S., Davis, A., Bartenschlager, R., Feinstone, S. & Rehermann, B. (2001). Oral immunization with HCV-NS3-transformed Salmonella: induction of HCV-specific CTL in a transgenic mouse model. Gastroenterology 121, 1158-1166.
59. You, Z., Huang, X., Hester, J., Toh, H. C. & Chen, S. Y. (2001). Targeting dendritic cells to enhance DNA vaccine potency. Cancer Res 61, 3704-3711.